Sign Up to Receive Your Personalised Learning Resources
Start Learning
Sign up to view Favourites, Keep Notes and Track CME Credits
Favourites
Trastuzumab Deruxtecan for the Treatment of HER2-low Advanced or Metastatic Breast Cancer
View
Quality and Reliability of Spanish-language YouTube Videos on Breast Cancer
View
Futibatinib for the Treatment of Previously Treated, Unresectable, Locally Advanced or Metastatic Intrahepatic Cholangiocarcinoma with Fibroblast Growth Factor Receptor 2 (FGFR2) Gene Fusions or Other Rearrangements
View
Durvalumab + tremelimumab vs. doxorubicin in soft tissue sarcoma – MEDISARC study: Viktor Grünwald, ESMO 2023
View
Decoding HER2 in NSCLC: Advances in biomarker testing and targeted therapies
View
Olutasidenib for Adults with Relapsed or Refractory Acute Myeloid Leukaemia with Isocitrate Dehydrogenase 1 Mutation
View
Global Liver Institute launches #OctoberIs4Livers campaign to combat rising liver cancer rates
View
Nivolumab plus Relatlimab alongside chemotherapy demonstrated improved clinical benefit in the RELATIVITY-104 trial
View
Immunotherapy for early-stage, resectable NSCLC: From clinical trial data to guidelines
View
Front-line consolidation therapy in B-ALL: current challenges and novel strategies
View